JAMA Network | JAMA | Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women: Women's Health Initiative Memory Study - 0 views
-
Nathan Goodyear on 06 Aug 13This was the WHI review of data as it pertains to dementia and cognitive decline in women. The take home here is that the data provides little evidence for premarin with or without medroxyprogesterone acetate in > 65 for prevention of dementia. However, this is in women > 65 and studies show that younger women do indeed receive benefit, especially in those with early ovary removal. Another point here, MPA (medroxyprogesterone acetate) increases cognitive decline. Just don't take MPA, it is a bad drug all the way around!